Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly EPS; no daily interpolation.
Limited quarterly history available
EPS needs at least three reported quarters before a meaningful chart is shown.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-0.08
EARNINGS PER SHARE (EPS) AVG 3Y
0.02
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Zhengye Biotechnology Holding Limited
Market Cap
$52.60M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.08
3Y Avg
0.02
5Y Avg
N/A
Market Cap
$52.83M
Earnings Per Share (EPS)
-0.35
TTM Avg
-0.57
3Y Avg
-0.69
5Y Avg
-0.62
Market Cap
$51.99M
Earnings Per Share (EPS)
N/A
TTM Avg
-7.29
3Y Avg
-67.66
5Y Avg
-178.24
Market Cap
$51.88M
Earnings Per Share (EPS)
-5.21
TTM Avg
-25.08
3Y Avg
-23.14
5Y Avg
-19.79
Market Cap
$53.70M
Earnings Per Share (EPS)
-1.00
TTM Avg
-1.43
3Y Avg
-2.38
5Y Avg
-2.90
Market Cap
$51.23M
Earnings Per Share (EPS)
-1.20
TTM Avg
-0.91
3Y Avg
-0.56
5Y Avg
-0.48
Market Cap
$51.19M
Earnings Per Share (EPS)
-1.49
TTM Avg
-1.25
3Y Avg
-158.58
5Y Avg
-880.75
Market Cap
$51.12M
Earnings Per Share (EPS)
-8.95
TTM Avg
-8.42
3Y Avg
-12.89
5Y Avg
-25.33
Market Cap
$54.14M
Earnings Per Share (EPS)
-0.27
TTM Avg
-0.75
3Y Avg
-1.03
5Y Avg
-0.90
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zhengye Biotechnology Holding Limited (ZYBT) | $52.60M | N/A | -0.08 | 0.02 | N/A |
| Spectral AI, Inc. (MDAI)vs › | $52.83M | -0.35 | -0.57 | -0.69 | -0.62 |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.99M | N/A | -7.29 | -67.66 | -178.24 |
| ImageneBio Inc (IMA)vs › | $51.88M | -5.21 | -25.08 | -23.14 | -19.79 |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $53.70M | -1.00 | -1.43 | -2.38 | -2.90 |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | -1.20 | -0.91 | -0.56 | -0.48 |
| Tenax Therapeutics, Inc. (TENX)vs › | $51.19M | -1.49 | -1.25 | -158.58 | -880.75 |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | -8.95 | -8.42 | -12.89 | -25.33 |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $54.14M | -0.27 | -0.75 | -1.03 | -0.90 |
| biote Corp. (BTMD)vs › | $50.28M | 0.12 | 0.48 | 0.24 | 1.52 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.20 |
| 2024-12-31 | 0.03 |
| 2023-12-31 | 0.10 |
| 2022-12-31 | 0.15 |
| 2021-12-31 | 0.13 |
